Implanet S.A. (EPA:ALIMP)

France · Delayed Price · Currency is EUR

0.210

+0.007 (3.45%)

At close: Feb 27, 2026

82.61% (1Y)

Market Cap	26.38M
Revenue (ttm)	11.10M
Net Income (ttm)	-4.81M
Shares Out	125.60M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	286,482
Average Volume	154,499
Open	0.218
Previous Close	0.203
Day's Range	0.200 - 0.218
52-Week Range	0.080 - 0.450
Beta	0.73
RSI	44.57
Earnings Date	Feb 24, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S.... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2006

Employees 46

Stock Exchange Euronext Paris

Ticker Symbol ALIMP

Full Company Profile

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.

Financial Statements

News

Implanet S.A. reports FY results

6 weeks ago - Seeking Alpha

Implanet S.A. reports Q3 results

5 months ago - Seeking Alpha